ALS TDI and to-BBB Form Collaboration To Find Drugs For ALS

The ALS Therapy Development Institute (ALS TDI) and to-BBB have announced their formal collaboration to find treatments for ALS. to-BBB is known for their development of a liposome-based drug delivery system capable of crossing the blood-brain barrier. ALS TDI will use to-BBB’s technology to facilitate transportation of potential ALS therapeutics across the blood-brain barrier in a pre-clinical mouse model of ALS. Dr. Steve Perrin, CEO and CSO of ALS TDI, said “This partnership brings a new potential tool to safely enhance the delivery of drugs that may slow or stop the progression of ALS. Being able to dose a drug systemically, but yet have it cross the blood-brain barrier, allows us to try things we weren’t able to do before. It enhances the arsenal of weapons we have available in our search for effective treatments for ALS.”

Click here to read more.

Share this: